The preoperative recurrence score: Predicting early recurrence in peri-hilar cholangiocarcinoma

  • 0Division of General and Hepatobiliary Surgery, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, University Hospital G.B. Rossi, Verona, Italy.

Summary

This summary is machine-generated.

A new Preoperative Recurrence Score (PRS) helps predict early recurrence in perihilar cholangiocarcinoma (PCC) patients. This radiological model aids in determining surgical suitability and preventing futile resections.

Area Of Science

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Radiology

Background

  • Perihilar cholangiocarcinoma (PCC) recurrence rates after surgery remain high.
  • Predictive models for early recurrence are needed to optimize treatment strategies.

Purpose Of The Study

  • To develop and validate the Preoperative Recurrence Score (PRS) model.
  • To estimate the risk of early recurrence based on preoperative radiological characteristics in PCC patients.

Main Methods

  • Retrospective collection of data from PCC patients who underwent surgery.
  • Review of preoperative imaging to identify key tumor characteristics.
  • Internal development and external validation of the PRS model on independent cohorts.

Main Results

  • Tumor size ≥18 mm, portal vein involvement, hepatic artery involvement, and suspicious lymph nodes were significant predictors of recurrence-free survival.
  • The PRS demonstrated excellent discrimination in internal (AUC 0.83) and external validation cohorts (AUC 0.84, 0.70).
  • High PRS was strongly associated with worse recurrence-free survival, with 1-year recurrence probabilities up to 100% in validation cohorts.

Conclusions

  • The Preoperative Recurrence Score (PRS) is a reliable tool for assessing early recurrence risk in PCC.
  • PRS can guide decisions regarding upfront surgery, potentially avoiding futile resections in high-risk patients.